Dermatologists Issue Warning over Viral Retinoid Trends: Return to the Pea-Sized Rule
Navigating the skin retinization process requires understanding the tangible line between acceptable adjustment side effects and destructive barrier breakdown. The table below details how measured application contrasts with excessive use over a standard twelve-week therapeutic course:
| Therapeutic Marker | Measured Pea-Sized Protocol | Overapplied Dose (>1 Gram) |
|---|---|---|
| Epidermal Tolerance | Mild micro-flaking limited to weeks 2, 4 | Intense facial peeling, raw patches, open fissuring |
| Vascular Response | Transient, faint flushing that resolves quickly | Persistent erythema, burning sensation, contact dermatitis |
| Transepidermal Water Loss (TEWL) | Stabilizes within normal baseline by week 6 | Elevated by 40%, 60%, leaving the barrier vulnerable |
| Treatment Adherence | Over 85% of patients maintain consistent long-term use | Frequent discontinuation due to intolerable pain |
